2008
DOI: 10.1245/s10434-008-0247-x
|View full text |Cite
|
Sign up to set email alerts
|

Adenocarcinoma of the Esophagogastric Junction: The Role of Abdominal-Transhiatal Resection

Abstract: The surgical strategy for adenocarcinoma of the esophagogastric junction is still controversial. The aim of this study was to evaluate surgical results of the abdominal-transhiatal approach for 100 consecutively operated type II and III cardia adenocarcinoma, to clarify clinicopathological differences between these tumors, and to define prognostic factors. A prospectively maintained database identified 100 consecutively operated patients with Siewert type II and III cardia adenocarcinoma. Survival was analyzed… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
23
1
1

Year Published

2011
2011
2020
2020

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 30 publications
(27 citation statements)
references
References 40 publications
2
23
1
1
Order By: Relevance
“…In our study, the overall survival rates at 1 year and 2 years were 89.2 and 69%, respectively. The median survival was 27.1 months, which was consistent with the reference in which adenocarcinoma of the EGJ was removed via the abdominal-transhiatal approach [6]. Studies have shown that the survival of patients with gastric adenocarcinoma is related to the number of regional lymph nodes with metastases [39].…”
Section: Discussionsupporting
confidence: 81%
See 1 more Smart Citation
“…In our study, the overall survival rates at 1 year and 2 years were 89.2 and 69%, respectively. The median survival was 27.1 months, which was consistent with the reference in which adenocarcinoma of the EGJ was removed via the abdominal-transhiatal approach [6]. Studies have shown that the survival of patients with gastric adenocarcinoma is related to the number of regional lymph nodes with metastases [39].…”
Section: Discussionsupporting
confidence: 81%
“…Surgery remains the standard care for adenocarcinoma of the EGJ. However, this tumor seems to constitute a distinct clinicopathological entity, and management remains controversial, especially as to the optimal surgical approach [6]. As a result, numerous randomized clinical trials have been conducted to evaluate the survival benefit of various treatment regimens [7,8,9].…”
Section: Introductionmentioning
confidence: 99%
“…The purpose of treatment is mostly palliative with expectation to prolong the life and improve the quality of life. Surgical treatment is the current treatment of choice for AEG patients [14]. Proximal gastrectomy and total gastrectomy through the abdominal approach have been widely used and proved to be a reliable surgical method for patients with types II and III AEG [3,14].…”
Section: Discussionmentioning
confidence: 99%
“…Surgical treatment is the current treatment of choice for AEG patients [14]. Proximal gastrectomy and total gastrectomy through the abdominal approach have been widely used and proved to be a reliable surgical method for patients with types II and III AEG [3,14]. Although there were reports [15] that noted high morbidity of the proximal gastrectomy with esophagogastric anastomosis, Harrison et al [16] reported that the long-term outcomes were not influenced by surgical procedures for proximal gastric cancer.…”
Section: Discussionmentioning
confidence: 99%
“…For AEG III tumors, transhiatal extended gastrectomy (THG) is proposed as the method of choice [8]. The optimal surgical strategy for AEG type II tumors remains unclear, some authors preferring an abdominal approach with THG, and other authors preferring a TAE [9][10][11][12][13][14][15]. In addition there are different possibilities for the surgical approach for TAE.…”
mentioning
confidence: 99%